Genetics of Beta Cell Failure in Mexican Americans

NCT ID: NCT03301519

Last Updated: 2023-11-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1250 participants

Study Classification

OBSERVATIONAL

Study Start Date

2001-07-01

Study Completion Date

2013-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a family based genotype-phenotype study designed to assess genetic and environmental influences on obesity, insulin resistance and beta cell function in the context of gestational diabetes.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Mexican American women with prior gestational diabetes and their first degree relatives and Mexican American women with prior normal glucose tolerance in pregnancy are studied with detailed phenotyping consisting of oral and intravenous glucose tolerance tests, body composition studies, diet and physical activity assessments, and circulating biomarkers potentially related to obesity, insulin resistance, pancreatic beta cell function, gestational diabetes and type 2 diabetes. Spouses of the gestational diabetic and control probands are studied with oral glucose tolerance tests. Offspring of the gestational and control probands have fasting glucose determinations. All participants provide DNA for genetics testing. A subset of the gestational diabetic probands and their first degree relatives return 3-5 years after baseline testing for repeat phenotyping.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gestational Diabetes Diabetes Type 2 Insulin Resistance Beta Cell Function Genetics Nutrition Physical Activity Adipokines Obesity Air Pollution

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Probands with Prior Gestational Diabetes Mellitus ("GDM PROBANDS")

* Mexican American (parents and at least 3/4 four grandparents
* age \>18 years
* GDM in singleton pregnancy in prior 5 years
* impaired glucose levels or sum of five OGTT glucose values \>625 mg/dl on 75 gram oral glucose tolerance test
* Fasting plasma glucose \<126 mg/dl
* At least two adult siblings of cousin not known to have diabetes and available for phenotyping; .
2. Siblings and Cousins of GDM Probands

* Full sibling or first cousin of GDM proband
* Age \>18 yrs
* Fasting plasma glucose \<126 mg/dl.
3. Parents, Uncles and Aunts of GDM Probands

* Full blooded parent, uncle or aunt of GDM proband
4. Control Proband

* Mexican American as defined for GDM probands
* One glucose challenge test result \<120 mg/dl at \>24 weeks gestation
* No diabetes in first degree relative
* Frequency matched to GDM probands by distributions of age, BMI and parity.
5. Spouse of GDM or Control Proband

* Spouse of GDM proband
* Age \>18
* At least one child with proband able to provide DNA
6. Child of Proband

* Child of GDM or control proband and spouse who provided DNA

Exclusion Criteria

1. PROBANDS (GDM OR CONTROL):

* Chronic medical illness or medication known to alter glucose/insulin metabolism
* Current pregnancy or breastfeeding
* Ilicit drug or alcohol abuse,
* Inability or unwillingness to give informed consent.
2. SIBLINGS AND COUSINS OF PROBANDS:

* Chronic medical illness or medication known to affect glucose/insulin metabolism
* Current pregnancy or breastfeeding,
* Ilicit drug or alcohol abuse
* Inability or unwillingness to give informed consent.
3. PARENTS OF PROBANDS

* Inability or unwillingness to give informed consent.
4. SPOUSE OF GDM or CONTROL PROBAND

* Inability or unwillingness to give informed consent.
5. CHILD OF GDM or CONTROL PROBAND

* Lack of parent consent or child assent.
Minimum Eligible Age

8 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Kaiser Permanente

OTHER

Sponsor Role collaborator

University of Southern California

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Thomas Buchanan

Professor of Medicine

Responsibility Role PRINCIPAL_INVESTIGATOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HS 013025

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.